2024 Pediatric Onco-Critical Care Symposium

Tuesday, April 16, 2024, 8:00 AM - Thursday, April 18, 2024, 7:00 PM, Marlo Thomas Center/Virtual, Memphis, TN

Outcomes for critically ill hematology/oncology and hematopoietic cell transplant patients, while improved over the last two decades, remain unacceptably poor compared with other patients we care for in our ICUs. The goal of this symposium is to advance the care of critically ill pediatric hematology/oncology patients through improvements in patient care, multidisciplinary collaboration, as well as clinical and translational research.

For more information, please visit the symposium website at www.stjude.org/POCCS

Onco-Critical Care Fundamentals Day

This educational pre-day will describe current literature and management of oncologic specific emergencies in critical care in all potential settings (including middle- and lower-income settings) and outline key differences between critically ill oncologic patients and critically ill general pediatric patients. Topics this year will include sepsis, neurologic dysfunction, tumor lysis syndrome, and ventilator management in pediatric oncology patients. Sessions will be lectures followed by expert panel discussion. Please bring all your questions!

Additional fee is $50 ($15 for LMIC participants).

Abstracts

To submit an abstract, please go to the Abstract Submission Site for more information. Abstracts must be submitted online via that site; no email submissions will be accepted.

Questions

If you have any questions about this symposium, please contact [email protected]. 

1. Determine which latest developments in POCCS are applicable to their practice and plan ways to implement them.

Please visit www.stjude.org/POCCS to register.

Registration Type	In-person attendees	Virtual attendees
Physicians, APPS, Nurses, RTs	$200 until 1/3/2024  $300 after 1/3/2024	$175 until 1/3/2024   $275 after 1/3/2024
Medical Trainees	$150 until 1/3/2024  $175 after 1/3/2024	$100 until 1/3/2024   $125 after 1/3/2024
LMIC attendees	$25	$25
St. Jude and Le Bonheur employees  and trainees	$75	$75

 

The Onco-Critical Care Fundamentals Day is an extra $50 ($15 for LMIC attendees). 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children’s Research Hospital and Le Bonheur Children's Hospital/University of Tennessee Health Science Center. St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.

This activity has been submitted to the American Association of Critical-Care Nurses for approval to award contact hours. The American Association of Critical-Care Nurses is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 18.25 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses may claim up to 8.5 Contact Hours in Nursing Continuing Professional Development Credit. Credit is commensurate with participation in the symposium. 

AMA PRA Category 1 Credits™ (18.25 hours), Non-Physician Attendance (18.25 hours), Nursing Continuing Professional Development Credit (8.50 hours)

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.